PB1926: REAL‐WORLD ERYTHROPOIESIS‐STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER‐RISK MYELODYSPLASTIC SYNDROMES (LR‐MDS) by Mukherjee, S., Zimmerman Savill, K., Gajra, A., Kish, J., Brown‐Bickerstaff, C., Gentile, D., Falkenstein, A., Miller, T., Laney, J., McBride, A.

Get full text

SA25 Physician Prescribing Preferences and Perceptions Surrounding First-LINE (1L) Noncytotoxic Combination Therapy for Mantle Cell Lymphoma (MCL) by Brown-Bickerstaff, C, Balanean, M.P.H., A, Klink, A, Gajra, A

Get full text

HSD16 Trends in Rheumatology Patient Care and Practice Operations Pre- and Post-COVID-19 Pandemic by Savill, K, Klink, A, Brown-Bickerstaff, C, Jeune-Smith, Y, Feinberg, B

Get full text

CO211 Real-World Treatment Patterns of Early-Stage Hepatocellular Carcinoma (HCC) after Complete Resection or Ablative Therapy: Retrospective, Medical Chart Review in the United St... by Brown-Bickerstaff, C., Singh, P., Kakehi, S., Garretson, M., Matteotti, R., Pathak, P., Laney, J., Feinberg, B.

Get full text

PMS25 Patient-Reported Outcome Labeling for Rheumatoid Arthritis Drugs Approved in the United States: 2010-2019 by Zettler, M., Brown-Bickerstaff, C., Savill, K., Gajra, A., Feinberg, B.

Get full text

EE225 Economic and Clinical Impact of a Novel, Antiviral Therapy on COVID-19 in the US by Gibson, S, Saunders, R, Stasko, N, Brown-Bickerstaff, C, Oakley, J, Osterman, M, Torres Torrejon, R, Kish, J, Feinberg, B, Emerson, D

Get full text